Search for a report

GLOBAL CRISPR MARKET FORECAST 2021-2028

  • You are here:
  • Home
  • Downloads
  • GLOBAL CRISPR MARKET FORECAST 2021-2028

GLOBAL CRISPR MARKET FORECAST 2021-2028

In terms of revenue, the global CRISPR market was valued at $xx million in 2020, and is expected to reach $4031.55 million by 2028, growing at a CAGR of 20.24% during the forecast period. The market study has also analyzed the impact of COVID-19 on the CRISPR industry qualitatively as well as quantitatively.

GLOBAL CRISPR MARKET FORECAST 2021-2028

Global CRISPR Market by Product (Plasmids, Vectors, Proteins, Designing Tools, Grna, Control Kits, Library, Other Products) Market by Application (Genome Editing/genetic Engineering, CRISPR Plasmid, Human Stem Cells, Grna Database/gene Library, Cell Line Engineering) Market by End-user (Therapeutics and Drug Discovery, Biological Research, Agricultural Biotech, Industrial Biotech) by Geography

Request free sample

In terms of revenue, the global CRISPR market was valued at $xx million in 2020, and is expected to reach $4031.55 million by 2028, growing at a CAGR of 20.24% during the forecast period. The market study has also analyzed the impact of COVID-19 on the CRISPR industry qualitatively as well as quantitatively. crispr-market

To learn more about this report, request a free sample copy

Key enablers of the global CRISPR market growth are:

  • Risk of congenital anomalies
  • Prevalence of genetic disorders
  • Growing use of CRISPR in Agriculture
    • The demand for CRISPR-Cas (CRISPR-associated proteins), particularly in the agriculture field, is growing due to its ability to precisely manipulate plant genomes. In addition, the current breeding systems have been overall revolutionized due to the development of novel varieties in agriculture.
    • Moreover, CRISPR–Cas has also facilitated the breeding of high-quality crops with the enrichment of carotenoid and γ-aminobutyric acid, which reduces the phytic acid and high oleic acid contents.
  • Growing awareness regarding gene therapeutics

Key factors restraining the market growth are:

  • Possible misuse of the CRISPR gene-editing tool
  • Lack of healthcare budgets in developing countries
  • Ethical issues
    • With the help of the CRISPR/Cas technology, it has been now possible to edit the genes or even whole genomes of many organisms, as there is no requirement for sophisticated knowledge or expensive equipment. This has further given rise to an ethical debate regarding this modification in living organisms’ genes.
    • Moreover, more immediate concerns arise when this technology of CRISPR is being used to modify insects, animals, plants, and micro-organisms. Due to the same reason, there has been a significant need to have effective global regulations required to govern the testing and environmental release of GMOs (Genetically Modified Organisms).

The report on the global CRISPR market includes the segmentation analysis of product type, application, and end-user.

Market by Product Type:

  • Plasmids
  • Vectors
  • Proteins
    • Proteins are anticipated to be the fastest-growing segment in the market by product type. Proteins are basically the most important molecules residing in every living cell, tissue, organ, or in short, inside the entire human body. Therefore, gene therapy could be considered as a form of protein therapy.
    • The protein therapy further uses quite well-defined, precisely structured proteins, along with already defined optimal doses of the individual protein for disease states, while also considering the well-known biological effects.
  • Designing Tools
  • GRNA
  • Control Kits
  • Library
  • Other Products

Geographically, the global CRISPR market has been segmented on the basis of four major regions, which includes:

  • North America: The United States & Canada
  • Europe: The United Kingdom, Germany, France, Italy, Russia, Netherlands, Switzerland, and Rest of Europe
  • Asia-Pacific: China, Japan, India, South Korea, Singapore, Thailand, Malaysia, Australia & New Zealand, and Rest of Asia Pacific
    • Asia-Pacific is anticipated to be the most dynamic regional market. It is expected to grow at a CAGR of 21.18% over the forecasted years. In addition, the region has seen an increment in CRISPR usage in the agriculture field, which has been further creating a stronger base for the prevalence of the CRISPR technology in major economies, such as China, Australia, and New Zealand.
    • The growth of CRISPR in China has been regulated by the government specifically to modify human reproduction technology. But, at the same time, CRISPR technology has been widely used in China so that the CRISPR-modified plants would provide enough food for its massive population.
    • In Australia & New Zealand, the government agreed to not regulate gene-editing techniques used in plants, animals, and human cell lines that guarantee to not introduce new genetic material. However, there is a need to further explore the development of any such modifications and understand any impact they would have on animals, which has to be thoroughly investigated on model organisms before its widespread use.
  • Rest of World: Latin America, the Middle East & Africa

The major players in the global CRISPR market are:

  • Addgene
  • CRISPR Therapeutics AG
  • Integrated DNA Technologies
  • New England Biolabs

Key strategies adopted by some of these companies:

In May 2021, Synthego obtained ISO 9001:2015 certification based on the quality standard requirements for the purpose of research and development of gene therapeutics and CRISPR-based gene editing. In April 2021, Horizon Discovery Group signed a multi-license agreement with IGM Biosciences to continue using Horizon’s cGMP-compliant CHOSOURCE™ platform. In March 2021, Caribou Biosciences raised $115 million in Series C Funding for improving its CRISPR technology.

Key trends of the global CRISPR market:

  • Industrial Biotech uses the different methods of gene-editing technology with the help of CRISPR to engineer renewed ways for the process of biosynthesis of industrial products. In addition, CRISPR-Cas systems further have the potential for several microbial engineering applications, including bacterial strain typing, immunization of cultures, etc., for improved biochemical synthesis.
  • Many key players such as Caribou Biosciences, Synthego Corporation, and CRISPR Therapeutics AG are currently investing in research and the production of different products and services in the CRISPR market.
  • Moreover, there has been a tremendous increase in the usage of potential applications of CRISPR technology, like making biofuel from an oil-rich strain of algae.

 

Frequently Asked Questions (FAQs):

  • Which is the major application in the CRISPR market?

A: Genome editing/genetic engineering is the major application in the CRISPR market.

  • Which country is set to project the fastest growth during the forecast period?

A: Australia & New Zealand is set to project the fastest growth with a CAGR of 21.73% during the forecast period.

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


    1. RESEARCH SCOPE & METHODOLOGY
      • STUDY OBJECTIVES
      • SCOPE OF STUDY
      • METHODOLOGY
      • ASSUMPTIONS & LIMITATIONS
    2. EXECUTIVE SUMMARY
      • MARKET SIZE & ESTIMATES
      • MARKET OVERVIEW
    3. MARKET DYNAMICS
      • KEY DRIVERS
        • RISK OF CONGENITAL ANOMALIES
        • PREVALENCE OF GENETIC DISORDERS
        • GROWING USE OF CRISPR IN AGRICULTURE
        • RISING AWARENESS REGARDING GENE THERAPEUTICS
      • KEY RESTRAINTS
        • POSSIBLE MISUSE OF CRISPR GENE-EDITING TOOL
        • LACK OF HEALTHCARE BUDGETS IN DEVELOPING COUNTRIES
        • ETHICAL ISSUES
    1. KEY ANALYTICS
      • IMPACT OF COVID-19 ON CRISPR MARKET
      • PATENT ANALYSIS
      • FUNDING SCENARIO
      • KEY MARKET TRENDS
      • PORTER’S FIVE FORCES ANALYSIS
        • BUYERS POWER
        • SUPPLIERS POWER
        • SUBSTITUTION
        • NEW ENTRANTS
        • INDUSTRY RIVALRY
      • OPPORTUNITY MATRIX
      • VENDOR LANDSCAPE
      • KEY BUYING CRITERIA
        • COST
        • ACCURACY
        • EASY TO USE
      • LEGAL & REGULATORY FRAMEWORK
    2. MARKET BY PRODUCT
      • PLASMIDS
      • VECTORS
      • PROTEINS
      • DESIGNING TOOLS
      • GRNA
      • CONTROL KITS
      • LIBRARY
      • OTHER PRODUCTS
    3. MARKET BY APPLICATION
      • GENOME EDITING/GENETIC ENGINEERING
      • CRISPR PLASMID
      • HUMAN STEM CELLS
      • GRNA DATABASE/GENE LIBRARY
      • CELL LINE ENGINEERING
    4. MARKET BY END-USER
      • THERAPEUTICS AND DRUG DISCOVERY
      • BIOLOGICAL RESEARCH
      • AGRICULTURAL BIOTECH
      • INDUSTRIAL BIOTECH
    5. GEOGRAPHICAL ANALYSIS
      • NORTH AMERICA
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • UNITED STATES
          • CANADA
      • EUROPE
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • UNITED KINGDOM
          • GERMANY
          • FRANCE
          • ITALY
          • RUSSIA
          • NETHERLANDS
          • SWITZERLAND
          • REST OF EUROPE
      • ASIA-PACIFIC
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • CHINA
          • JAPAN
          • INDIA
          • SOUTH KOREA
          • SINGAPORE
          • THAILAND
          • MALAYSIA
          • AUSTRALIA & NEW ZEALAND
          • REST OF ASIA-PACIFIC
      • REST OF WORLD
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • LATIN AMERICA
          • MIDDLE EAST AND AFRICA
    1. COMPETITIVE LANDSCAPE
      • KEY STRATEGIC DEVELOPMENTS
        • MERGERS & ACQUISITIONS
        • PRODUCT LAUNCHES & DEVELOPMENTS
        • PARTNERSHIPS & AGREEMENTS
        • BUSINESS EXPANSIONS & DIVESTITURES
      • COMPANY PROFILES
        • ADDGENE
        • CARIBOU BIOSCIENCES INC
        • CELLECTIS BIORESEARCH SAS
        • CRISPR THERAPEUTICS AG
        • EDITAS MEDICINE
        • GENSCRIPT
        • HORIZON DISCOVERY GROUP
        • INTEGRATED DNA TECHNOLOGIES
        • INTELLIA THERAPEUTICS
        • LONZA GROUP LTD
        • NEW ENGLAND BIOLABS
        • NOVARTIS INTERNATIONAL AG
        • ORIGENE TECHNOLOGIES INC
        • PRECISION BIOSCIENCES
        • SYNTHEGO CORPORATION
        • THERMO FISHER SCIENTIFIC INC

    LIST OF TABLES  

    TABLE 1: MARKET SNAPSHOT – CRISPR

    TABLE 2: FUNDING SCENARIO OF PUBLIC COMPANIES

    TABLE 3: FUNDING SCENARIO OF PRIVATE COMPANIES

    TABLE 4: FUNDING SCENARIO OF GOVERNMENT ORGANIZATIONS

    TABLE 5: REGULATORY FRAMEWORK

    TABLE 6: GLOBAL CRISPR MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 7: GLOBAL CRISPR MARKET, BY PRODUCT, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 8: GLOBAL PLASMIDS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 9: GLOBAL PLASMIDS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 10: GLOBAL VECTORS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 11: GLOBAL VECTORS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 12: GLOBAL PROTEINS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 13: GLOBAL PROTEINS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 14: GLOBAL DESIGNING TOOLS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 15: GLOBAL DESIGNING TOOLS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 16: GLOBAL GRNA MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 17: GLOBAL GRNA MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 18: GLOBAL CONTROL KITS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 19: GLOBAL CONTROL KITS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 20: GLOBAL LIBRARY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 21: GLOBAL LIBRARY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 22: GLOBAL OTHER PRODUCTS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 23: GLOBAL OTHER PRODUCTS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 24: GLOBAL CRISPR MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 25: GLOBAL CRISPR MARKET, BY APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 26: GLOBAL GENOME EDITING/GENETIC ENGINEERING MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 27: GLOBAL GENOME EDITING/GENETIC ENGINEERING MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 28: GLOBAL CRISPR PLASMID MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 29: GLOBAL CRISPR PLASMID MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 30: GLOBAL HUMAN STEM CELLS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 31: GLOBAL HUMAN STEM CELLS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 32: GLOBAL GRNA DATABASE/GENE LIBRARY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 33: GLOBAL GRNA DATABASE/GENE LIBRARY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 34: GLOBAL CELL LINE ENGINEERING MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 35: GLOBAL CELL LINE ENGINEERING MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 36: GLOBAL CRISPR MARKET, BY END-USER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 37: GLOBAL CRISPR MARKET, BY END-USER, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 38: GLOBAL THERAPEUTICS AND DRUG DISCOVERY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 39: GLOBAL THERAPEUTICS AND DRUGS DISCOVERY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 40: GLOBAL BIOLOGICAL RESEARCH MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 41: GLOBAL BIOLOGICAL RESEARCH MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 42: GLOBAL AGRICULTURAL BIOTECH MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 43: GLOBAL AGRICULTURAL BIOTECH MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 44: GLOBAL INDUSTRIAL BIOTECH MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 45: GLOBAL INDUSTRIAL BIOTECH MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 46: GLOBAL CRISPR MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 47: GLOBAL CRISPR MARKET, BY GEOGRAPHY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 48: NORTH AMERICA CRISPR MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 49: NORTH AMERICA CRISPR MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 50: LEADING PLAYERS OPERATING IN NORTH AMERICA CRISPR MARKET

    TABLE 51: EUROPE CRISPR MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 52: EUROPE CRISPR MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 53: LEADING PLAYERS OPERATING IN EUROPE CRISPR MARKET

    TABLE 54: ASIA-PACIFIC CRISPR MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 55: ASIA-PACIFIC CRISPR MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 56: LEADING PLAYERS OPERATING IN ASIA-PACIFIC CRISPR MARKET

    TABLE 57: REST OF WORLD CRISPR MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 58: REST OF WORLD CRISPR MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 59: LEADING PLAYERS OPERATING IN REST OF WORLD CRISPR MARKET

    TABLE 60: LIST OF MERGERS & ACQUISITIONS

    TABLE 61: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

    TABLE 62: LIST OF PARTNERSHIPS & AGREEMENTS

    TABLE 63: LIST OF BUSINESS EXPANSIONS & DIVESTITURES

    LIST OF FIGURES 

    FIGURE 1: FUNDING SCENARIO SHARE, BY TYPE OF COMPANIES/ORGANIZATION

    FIGURE 2: KEY MARKET TRENDS

    FIGURE 3: PORTER’S FIVE FORCES ANALYSIS

    FIGURE 4: OPPORTUNITY MATRIX

    FIGURE 5: VENDOR LANDSCAPE

    FIGURE 6: KEY BUYING CRITERIA

    FIGURE 7: GLOBAL CRISPR MARKET, GROWTH POTENTIAL, BY PRODUCT, IN 2020

    FIGURE 8: GLOBAL CRISPR MARKET, BY PLASMIDS, 2021-2028 (IN $ MILLION)

    FIGURE 9: GLOBAL CRISPR MARKET, BY VECTORS, 2021-2028 (IN $ MILLION)

    FIGURE 10: GLOBAL CRISPR MARKET, BY PROTEINS, 2021-2028 (IN $ MILLION)

    FIGURE 11: GLOBAL CRISPR MARKET, BY DESIGNING TOOLS, 2021-2028 (IN $ MILLION)

    FIGURE 12: GLOBAL CRISPR MARKET, BY GRNA, 2021-2028 (IN $ MILLION)

    FIGURE 13: GLOBAL CRISPR MARKET, BY CONTROL KITS, 2021-2028 (IN $ MILLION)

    FIGURE 14: GLOBAL CRISPR MARKET, BY LIBRARY, 2021-2028 (IN $ MILLION)

    FIGURE 15: GLOBAL CRISPR MARKET, BY OTHER PRODUCTS, 2021-2028 (IN $ MILLION)

    FIGURE 16: GLOBAL CRISPR MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2020

    FIGURE 17: GLOBAL CRISPR MARKET, BY GENOME EDITING/GENETIC ENGINEERING, 2021-2028 (IN $ MILLION)

    FIGURE 18: GLOBAL CRISPR MARKET, BY CRISPR PLASMID, 2021-2028 (IN $ MILLION)

    FIGURE 19: GLOBAL CRISPR MARKET, BY HUMAN STEM CELLS, 2021-2028 (IN $ MILLION)

    FIGURE 20: GLOBAL CRISPR MARKET, BY GRNA DATABASE/GENE LIBRARY, 2021-2028 (IN $ MILLION)

    FIGURE 21: GLOBAL CRISPR MARKET, BY CELL LINE ENGINEERING, 2021-2028 (IN $ MILLION)

    FIGURE 22: GLOBAL CRISPR MARKET, GROWTH POTENTIAL, BY END-USER, IN 2020

    FIGURE 23: GLOBAL CRISPR MARKET, BY THERAPEUTICS AND DRUGS DISCOVERY, 2021-2028 (IN $ MILLION)

    FIGURE 24: GLOBAL CRISPR MARKET, BY BIOLOGICAL RESEARCH, 2021-2028 (IN $ MILLION)

    FIGURE 25: GLOBAL CRISPR MARKET, BY AGRICULTURAL BIOTECH, 2021-2028 (IN $ MILLION)

    FIGURE 26: GLOBAL CRISPR MARKET, BY INDUSTRIAL BIOTECH, 2021-2028 (IN $ MILLION)

    FIGURE 27: NORTH AMERICA CRISPR MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)

    FIGURE 28: UNITED STATES CRISPR MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 29: CANADA CRISPR MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 30: EUROPE CRISPR MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)

    FIGURE 31: UNITED KINGDOM CRISPR MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 32: GERMANY CRISPR MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 33: FRANCE CRISPR MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 34: ITALY CRISPR MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 35: RUSSIA CRISPR MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 36: NETHERLANDS CRISPR MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 37: SWITZERLAND CRISPR MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 38: REST OF EUROPE CRISPR MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 39: ASIA-PACIFIC CRISPR MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)

    FIGURE 40: CHINA CRISPR MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 41: JAPAN CRISPR MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 42: INDIA CRISPR MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 43: SOUTH KOREA CRISPR MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 44: SINGAPORE CRISPR MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 45: THAILAND CRISPR MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 46: MALAYSIA CRISPR MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 47: AUSTRALIA & NEW ZEALAND CRISPR MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 48: REST OF ASIA-PACIFIC CRISPR MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 49: REST OF WORLD CRISPR MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)

    FIGURE 50: LATIN AMERICA CRISPR MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 51: MIDDLE EAST AND AFRICA CRISPR MARKET, 2021-2028 (IN $ MILLION)

    1. MARKET BY PRODUCT
      • PLASMIDS
      • VECTORS
      • PROTEINS
      • DESIGNING TOOLS
      • GRNA
      • CONTROL KITS
      • LIBRARY
      • OTHER PRODUCTS
    2. MARKET BY APPLICATION
      • GENOME EDITING/GENETIC ENGINEERING
      • CRISPR PLASMID
      • HUMAN STEM CELLS
      • GRNA DATABASE/GENE LIBRARY
      • CELL LINE ENGINEERING
    3. MARKET BY END-USER
      • THERAPEUTICS AND DRUG DISCOVERY
      • BIOLOGICAL RESEARCH
      • AGRICULTURAL BIOTECH
      • INDUSTRIAL BIOTECH
    4. GEOGRAPHICAL ANALYSIS
      • NORTH AMERICA
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • UNITED STATES
          • CANADA
      • EUROPE
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • UNITED KINGDOM
          • GERMANY
          • FRANCE
          • ITALY
          • RUSSIA
          • NETHERLANDS
          • SWITZERLAND
          • REST OF EUROPE
      • ASIA-PACIFIC
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • CHINA
          • JAPAN
          • INDIA
          • SOUTH KOREA
          • SINGAPORE
          • THAILAND
          • MALAYSIA
          • AUSTRALIA & NEW ZEALAND
          • REST OF ASIA-PACIFIC
      • REST OF WORLD
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • LATIN AMERICA
          • MIDDLE EAST AND AFRICA

    To request a free sample copy of this report, please complete the form below :

    We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


      Choose License Type

      Buy Now